Small Biotechs Could Suffer Under State Bans On Selling Physician Rx Data, BIO Says

Bans on the practice, like the recently upheld New Hampshire law, could have an unintended financial consequence on small biotech companies, BIO warns.

More from Archive

More from Pink Sheet